Detailed information for compound 149110

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 389.757 | Formula: C16H15ClF3N3O3
  • H donors: 3 H acceptors: 2 LogP: 3.61 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: OC(=O)C(F)(F)F.NC(=N)Nc1cccc(c1)OCc1ccc(cc1)Cl
  • InChi: 1S/C14H14ClN3O.C2HF3O2/c15-11-6-4-10(5-7-11)9-19-13-3-1-2-12(8-13)18-14(16)17;3-2(4,5)1(6)7/h1-8H,9H2,(H4,16,17,18);(H,6,7)
  • InChiKey: SGWMUZDYGCTNHE-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Loa Loa (eye worm) MH2 domain-containing protein 0.0075 0.0927 0.5
Trypanosoma brucei mitochondrial DNA polymerase beta 0.019 0.3323 1
Mycobacterium ulcerans hypothetical protein 0.01 0.1448 0.3552
Leishmania major mitochondrial DNA polymerase beta-PAK, putative 0.009 0.1236 0.3407
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative 0.019 0.3323 1
Mycobacterium ulcerans 3-phosphoshikimate 1-carboxyvinyltransferase 0.0114 0.1743 0.4365
Brugia malayi MH2 domain containing protein 0.0075 0.0927 0.5
Mycobacterium ulcerans 3-dehydroquinate synthase 0.0213 0.379 1
Mycobacterium leprae 3-dehydroquinate synthase AroB 0.0213 0.379 1
Mycobacterium tuberculosis 3-phosphoshikimate 1-carboxyvinyltransferase AroA (5-enolpyruvylshikimate-3-phosphate synthase) (EPSP synthase) (EPSPS) 0.0114 0.1743 0.4365
Schistosoma mansoni 3-dehydroquinate synthase 0.0213 0.379 1
Mycobacterium tuberculosis 3-dehydroquinate synthase AroB 0.0213 0.379 1
Toxoplasma gondii shikimate dehydrogenase substrate binding domain-containing protein 0.0213 0.379 1
Leishmania major mitochondrial DNA polymerase beta 0.019 0.3323 1
Trypanosoma cruzi mitochondrial DNA polymerase beta-PAK, putative 0.009 0.1236 0.3643
Chlamydia trachomatis dehyroquinate synthase 0.0213 0.379 1
Echinococcus granulosus aldehyde dehydrogenase mitochondrial 0.0038 0.0158 0.5
Loa Loa (eye worm) transcription factor SMAD2 0.0075 0.0927 0.5
Mycobacterium tuberculosis Conserved hypothetical protein 0.01 0.1448 0.3552
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative 0.019 0.3323 1
Toxoplasma gondii aldehyde dehydrogenase 0.0038 0.0158 0.0416

Activities

Activity type Activity value Assay description Source Reference
Activity (ADMET) = 100 uM Toxicity of the compound against HIV cells ChEMBL. 15109676
IC50 (functional) 0 uM Inhibition of HIV-cell fusion was determined at 10 microM by using cellular FIGS assay; Inactive ChEMBL. 15109676

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.